Its dual agonist mechanism simultaneously activates both the GIP receptor (GIPR) and the GLP-1 receptor (GLP-1R), producing synergistic effects on glucose homeostasis, appetite regulation, and adipose tissue metabolism that exceed those achievable through either pathway alone [1]
Without that cushion, your face may look thinner but it can also appear gaunt, with sagging cheeks, jowls, or loose skin along the jawline
Concurrent Medications: Some drugs can counteract Ozempic's effects or induce weight gain
A firm, non-tender nodule that gradually softens over 57 days represents benign localized fibrosis from chemical irritation and does not require treatment cessation
Self-administered subcutaneous injection of unverified peptide preparations carries risks including infection, embolism, and unknown impurity toxicity